Tue, 06th Jul 2021 15:52
Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Chief Business Officer Jason Slingsby exercises nil-cost options for 1,584 shares and sells all of them for 1,298.5 pence each, worth GBP20,569, on Friday last week.
Current stock price: 1,326.52p
Year-to-date change: up 29%
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:
(Alliance News) - The FTSE 100 in London closed higher on Monday, outperforming its European counterparts, as investors eye this week's interest rate ...
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core bu...
Oxford Biomedica (OXB)